Our Team
Behind every milestone is a dedicated team of leaders, experts, and innovators working together to build a healthier and more sustainable future.
Leadership Team
People Driving Our Vision
Forward
Our team brings together diverse expertise across pharmaceutical operations, quality, commercial strategy, finance, regulatory affairs, compliance, supply chain, marketing, and corporate leadership.
Adam El Daba Founder & CEO
Gennecs Pharmaceutical / Gennvax
Adam Eldaba is a prominent entrepreneur with extensive experience in establishing, growing, and selling businesses across various sectors. He is the Founder and CEO of Gennecs Pharmaceuticals, the pharmaceutical arm of Eldaba Holding Group, and the main sponsor and investor of Gennvax, the company’s vaccine development division.
With his entrepreneurial acumen, Adam has successfully founded, scaled, and exited multiple businesses in industries such as real estate, F&B, IT, trading, and healthcare.
Additionally, he has invested in over 18 companies across 5 countries, demonstrating his deep understanding of diverse industries and his ability to identify promising opportunities for investment and growth.
Adam’s leadership skills and expertise have made him a notable figure in the business world, and his work with Gennecs Pharmaceuticals and Gennvax have established them as major players in the healthcare industry.
Nibal Dahaba, General Manager
Gennecs Pharmaceutical / Gennvax
Nibal Dahaba is a dynamic leader with extensive experience in the pharmaceutical industry. As the General Manager of Gennecs Holding/Gennvax, Nibal has continued to demonstrate her passion for making a difference in healthcare.
She previously served as the Head of Sanofi Pasteur (Egypt & Africa), where she launched the business across the continent and made a significant impact on the National Immunization Program (NIP) in Africa. With a strong track record of success, Nibal has also held executive positions at global pharmaceutical giants such as Merck, Abbvie, and Novartis.
Her impressive achievements include sealing deals with UNICEF, WHO, and several African governments. Nibal was also instrumental in rolling out the Virus C treatment supply across Egypt as the main liaison between the Egyptian and U.S governments. Nibal Dahaba’s leadership and expertise have made her a driving force in the pharmaceutical industry.
Mostafa Al-Afifi
Mohamed Hamdy
HR Director
Rehab Abdel-Fatah
Khaled Salah
Osama Hassan
Ahmed Kouta
Head of Finance
Mohamed Khedr
Adam El Daba Founder & CEO
Gennecs Pharmaceutical / Gennvax
Adam Eldaba is a prominent entrepreneur with extensive experience in establishing, growing, and selling businesses across various sectors. He is the Founder and CEO of Gennecs Pharmaceuticals, the pharmaceutical arm of Eldaba Holding Group, and the main sponsor and investor of Gennvax, the company’s vaccine development division.
With his entrepreneurial acumen, Adam has successfully founded, scaled, and exited multiple businesses in industries such as real estate, F&B, IT, trading, and healthcare.
Additionally, he has invested in over 18 companies across 5 countries, demonstrating his deep understanding of diverse industries and his ability to identify promising opportunities for investment and growth.
Adam’s leadership skills and expertise have made him a notable figure in the business world, and his work with Gennecs Pharmaceuticals and Gennvax have established them as major players in the healthcare industry.
Nibal Dahaba, General Manager
Gennecs Pharmaceutical / Gennvax
Nibal Dahaba is a dynamic leader with extensive experience in the pharmaceutical industry. As the General Manager of Gennecs Holding/Gennvax, Nibal has continued to demonstrate her passion for making a difference in healthcare.
She previously served as the Head of Sanofi Pasteur (Egypt & Africa), where she launched the business across the continent and made a significant impact on the National Immunization Program (NIP) in Africa. With a strong track record of success, Nibal has also held executive positions at global pharmaceutical giants such as Merck, Abbvie, and Novartis.
Her impressive achievements include sealing deals with UNICEF, WHO, and several African governments. Nibal was also instrumental in rolling out the Virus C treatment supply across Egypt as the main liaison between the Egyptian and U.S governments. Nibal Dahaba’s leadership and expertise have made her a driving force in the pharmaceutical industry.
Mostafa Al-Afifi
Legal & Compliance Director
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since 1966, when designers at Letraset and James Mosley, the librarian at St Bride Printing Library, took a 1914 Cicero translation and scrambled it to make dummy text for Letraset’s Body Type sheets. It has survived not only many decades, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised thanks to these sheets and more recently with desktop publishing software including versions of Lorem Ipsum.
Why do we use it?
It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to using ‘Content here, content here’, making it look like readable English. Many desktop publishing packages and web page
Mostafa Al-Afifi
Legal & Compliance Director
Mohamed Hamdy
HR Director
Osama Hassan
Mohamed Khedr
Ahmed Kouta
Head of Finance
Khaled Salah
Rehab Abdel-Fatah
United by Purpose
We believe strong leadership is built on integrity, innovation, respect, and a shared commitment to improving access to treatment and vaccination coverage.